KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Assets: 2009-2024

Historic Return on Assets for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -0.05%.

  • Teva Pharmaceutical Industries' Return on Assets rose 8.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 8.00%. This contributed to the annual value of -0.05% for FY2024, which is 3.00% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Return on Assets stood at -0.05% for FY2024, which was down 235.64% from -0.01% recorded in FY2023.
  • Teva Pharmaceutical Industries' Return on Assets' 5-year high stood at 0.01% during FY2021, with a 5-year trough of -0.08% in FY2020.
  • Its 3-year average for Return on Assets is -0.04%, with a median of -0.05% in 2024.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Return on Assets decreased by 6bps in 2020, and later increased by 9bps in 2021.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Return on Assets stood at -0.08% in 2020, then grew by 9bps to 0.01% in 2021, then fell by 6bps to -0.05% in 2022, then climbed by 4bps to -0.01% in 2023, then declined by 3bps to -0.05% in 2024.